BioCentury
ARTICLE | Finance

Dozens of investors seek liquidity as Grail files for IPO ahead of commercial launches

September 9, 2020 9:24 PM UTC

Liquidity is looming for the long list of investors who poured $1.9 billion into Grail, now that the early cancer detection company has filed for an IPO on NASDAQ.

Grail Inc. hasn’t yet set terms of the offering, which would come ahead of a planned 2021 commercial launch of the company’s Galleri product. But given the amount of private funding the company has raised since early 2016, Grail could easily command a valuation among the highest of the biotechs going public this year...

BCIQ Company Profiles

Grail Inc.